Gabriel S. Morris is CFO at Immix Biopharma, Inc. (IMMX). They have made 8 open-market trades across 1 company since 2021, most recently 2025-12-10.
CIK 0001889967
8 open-market purchases totalling $51K since 2021, never a sale. Across 8 scored buys the stock is up 35.8% at ninety days, and 33.3 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMMX | 291,429 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2025-12-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 63% | 38% |
| Avg Move | +2.2% | +24.1% | +35.8% |
| Alpha | +0.6% | +22.1% | +33.3% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMMX | BUY | 2025-12-10 | 2025-12-10 | $6.58 | $5K | -14.8% | -28.6% | +52.5% |
| IMMX | BUY | 2025-09-16 | 2025-09-17 | $1.97 | $5K | -0.5% | +37.3% | +184.2% |
| IMMX | BUY | 2025-06-18 | 2025-06-20 | $2.28 | $5K | +5.1% | +30.4% | -8.9% |
| IMMX | BUY | 2024-06-07 | 2024-06-10 | $2.12 | $5K | -1.4% | -1.4% | -4.8% |
| IMMX | BUY | 2024-06-04 | 2024-06-05 | $1.81 | $6K | +0.0% | +15.1% | -0.5% |
| IMMX | BUY | 2024-05-14 | 2024-05-14 | $2.23 | $10K | -0.9% | -8.4% | -18.5% |
| IMMX | BUY | 2022-11-14 | 2022-11-15 | $0.94 | $5K | +23.6% | +79.1% | +116.4% |
| IMMX | BUY | 2021-12-20 | 2021-12-20 | $5.00 | $10K | +6.3% | +69.0% | -33.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.